Rite Aid Foundation donates $50,000 to American Red Cross’ Hurricane Irene relief efforts
CAMP HILL, Pa. — Rite Aid’s philanthropic arm is donating $50,000 to Hurricane Irene relief efforts, Rite Aid said Wednesday.
The retail pharmacy chain said the Rite Aid Foundation was making the donation to the American Red Cross, in addition to donations of baby formula, personal hygiene products, first aid and cleaning supplies to several nonprofit organizations in New York and Vermont — areas that were particularly affected by the hurricane.
"One of Rite Aid’s core values is to be a caring neighbor in the communities we serve, and that’s especially true in times like these as communities start to rebuild," Rite Aid Foundation president and Rite Aid chairman Mary Sammons said. "We are proud to partner with the American Red Cross and hope our donation makes things a little easier for those who have been most affected by Hurricane Irene."
No comments found
GNC announces sponsorship of Wounded Warrior golf outing
PITTSBURGH — GNC on Monday announced that it again is partnering with the Western Pennsylvania Committee of the Wounded Warrior Project as lead sponsor of its annual golf outing to be held Sept. 19 at the Diamond Run Golf Club in Sewickley, Pa.
The charity event is designed to raise public awareness and funding for severely wounded servicemen and women to help them recover and transition back to civilian life. To date, GNC has helped raise more than $340,000 for the Wounded Warrior Project to support its programs and services.
For a $350 donation, participants can sponsor a “Warrior,” giving him or her the opportunity to enjoy a day on the golf course. Other sponsorships are available as well, and all proceeds benefit the Wounded Warrior Project, GNC stated.
No comments found
FDA accepts new drug application from Vivus
MOUNTAIN VIEW, Calif. — The Food and Drug Administration has accepted a regulatory approval application for a drug made by Vivus for treating erectile dysfunction.
Vivus said it expected the Food and Drug Administration to complete its review of the application for avanafil by April 29, 2012.
"We are pleased with FDA’s acceptance of our NDA," Vivus president Peter Tam said. "If approved, avanafil could be a valuable treatment alternative for the 18 million men in the United States that suffer from ED."
I personally do not see how this drug will not be approved. While the FDA makes the supreme judgment, there seems to be little apprehension in its overall efficacy and side effects. The short duration between ingestion and working of the drug seem very favorable compared to other PDE5 inhibitors currently on the market.